Search - tctmd.com

Displaying 1 - 20 of 66

Sort: Relevancy | Date

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Caitlin E. Cox

February 02, 2026

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

Todd Neale

September 18, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Michael O'Riordan

June 13, 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Michael O'Riordan

May 14, 2025

News Daily News

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Michael O'Riordan

February 07, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

L.A. McKeown

January 10, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

Taxes on Sugar-Sweetened Beverages Linked to Lower BMI in Children

Yael L. Maxwell

July 31, 2024

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

Advertisement

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Heart Disease Remains Number One Killer of Americans

JACC Debuts Data Digest on CV Health in the United States

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

October 2025 Dispatch for the CV Team

CVD Still the Leading Cause of Death and Disease Globally

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

July 2025 Dispatch for the CV Team

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

CVD Hospitalization in Older Adults Higher in US Than in Denmark

January 2025 Dispatch for the CV Team

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

December 2024 Dispatch for the CV Team

Taxes on Sugar-Sweetened Beverages Linked to Lower BMI in Children

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Semaglutide Has Similar Benefits in Women and Men With HFpEF

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content